HK1041889B - 治療癌症的新化合物 - Google Patents

治療癌症的新化合物

Info

Publication number
HK1041889B
HK1041889B HK02103709.4A HK02103709A HK1041889B HK 1041889 B HK1041889 B HK 1041889B HK 02103709 A HK02103709 A HK 02103709A HK 1041889 B HK1041889 B HK 1041889B
Authority
HK
Hong Kong
Prior art keywords
cancer
treatment
doxorubicin
new compounds
compounds
Prior art date
Application number
HK02103709.4A
Other languages
English (en)
Other versions
HK1041889A1 (en
Inventor
Strelchenok Oleg
Original Assignee
阿登尼亞投資有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900878A external-priority patent/SE9900878D0/xx
Priority claimed from SE9900941A external-priority patent/SE9900941D0/xx
Application filed by 阿登尼亞投資有限公司 filed Critical 阿登尼亞投資有限公司
Publication of HK1041889A1 publication Critical patent/HK1041889A1/xx
Publication of HK1041889B publication Critical patent/HK1041889B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02103709.4A 1999-03-11 2002-05-16 治療癌症的新化合物 HK1041889B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900878A SE9900878D0 (sv) 1998-12-23 1999-03-11 New composition and use thereof
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use
PCT/IB1999/002062 WO2000042832A2 (en) 1999-03-11 1999-12-28 New compounds for the treatment of cancer

Publications (2)

Publication Number Publication Date
HK1041889A1 HK1041889A1 (en) 2002-07-26
HK1041889B true HK1041889B (zh) 2005-03-18

Family

ID=26663529

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103709.4A HK1041889B (zh) 1999-03-11 2002-05-16 治療癌症的新化合物

Country Status (10)

Country Link
EP (1) EP1159756B1 (zh)
JP (1) JP4643009B2 (zh)
CN (1) CN1149219C (zh)
AT (1) ATE332013T1 (zh)
AU (1) AU766256B2 (zh)
CA (1) CA2358420C (zh)
DE (1) DE69932187T2 (zh)
HK (1) HK1041889B (zh)
ID (1) ID29246A (zh)
WO (1) WO2000042832A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161436B1 (en) * 1999-03-16 2003-06-25 Ardenia Investments Ltd. Polyunsaturated fatty acid derivatives and their use in the treatment of cancer
AU2001268007A1 (en) * 2000-07-12 2002-01-21 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US6613753B2 (en) * 2001-02-21 2003-09-02 Supergen, Inc. Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
AUPR395801A0 (en) * 2001-03-26 2001-04-26 Austin Research Institute, The Antibodies against cancer
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
JP7041673B2 (ja) * 2016-10-13 2022-03-24 カーノット， エルエルシー Ｎ－アシルエタノールアミド誘導体およびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101678B (fi) * 1990-12-31 1998-08-14 Akzo Nv Happolabiileja kytkentämolekyylejä

Also Published As

Publication number Publication date
DE69932187T2 (de) 2007-05-24
JP4643009B2 (ja) 2011-03-02
ID29246A (id) 2001-08-16
CN1332745A (zh) 2002-01-23
CA2358420C (en) 2010-03-16
EP1159756A2 (en) 2001-12-05
JP2002535251A (ja) 2002-10-22
HK1041889A1 (en) 2002-07-26
CA2358420A1 (en) 2000-07-27
EP1159756B1 (en) 2006-06-28
WO2000042832A3 (en) 2001-02-01
CN1149219C (zh) 2004-05-12
ATE332013T1 (de) 2006-07-15
WO2000042832A2 (en) 2000-07-27
AU766256B2 (en) 2003-10-09
DE69932187D1 (de) 2006-08-10
AU1581800A (en) 2000-08-07

Similar Documents

Publication Publication Date Title
WO2000006134A3 (en) Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
NZ540385A (en) Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer
PL365783A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
MY125978A (en) Admantane derivatives
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
MY138883A (en) Use of asiatic acid for treatment of cencer
HUP9904092A3 (en) Pharmaceutical composition for treatment hiv and cancer and process for producing it
HK1038508A1 (en) Dosage form comprising liquid formulation
HK1041889A1 (en) New compounds for the treatment of cancer.
CA2429639A1 (en) Stable azithromycin monohydrate
RS53804A (en) Parenteral composition of paracetamol
MXPA03001227A (es) Composiciones neuroprotectoras de 2-piridinamina y metodos relacionados.
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
MY128859A (en) Compounds for the treatment of cancer
WO1999056697A3 (en) Pharmaceutical composition
CA98132S (en) Tabletop folder/inserter
EP1374873B8 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
MXPA02007296A (es) Composicion farmaceutica que comprende portadores para productos basados en vitamina 3, papaina e hialuronidasa.
GR1004016B (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
NZ507349A (en) Spisulosine Compounds having antitumour activity
UA42462A (uk) Бромідний комплекс міді (іі) та кобальту (ііі) з діетаноламіном, що виявляє протипухлинну дію
UA845U (uk) Виконавчий орган гірничопрохідницької машини
IL145940A0 (en) Use of antiprogestagens in combined therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171228